Amgen (AMGN) Amortization - Intangibles (2009 - 2012)
Amgen (AMGN) posted quarterly Amortization - Intangibles of $73.0 million for Q4 2012, little changed year-over-year from $73.0 million in Q1 2012, and down 1.35% quarter-over-quarter from $74.0 million in Q3 2012.
Amgen (AMGN) Amortization - Intangibles (2009 - 2012) Analysis & Trends
Amgen's Amortization - Intangibles history runs 4 years deep, the most recent figure standing at $73.0 million for Q4 2012.
- In Q4 2012, Amortization - Intangibles changed 0.0% year-over-year to $73.0 million; the TTM figure through Dec 2012 stood at $294.0 million (changed 0.0% YoY), while the FY2012 annual figure was $294.0 million, changed 0.0% from the prior year.
- Amortization - Intangibles for Q4 2012 stood at $73.0 million, down from $74.0 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $74.0 million in Q1 2009, with the low at $73.0 million in Q2 2009.
- The 4-year median for Amortization - Intangibles is $73.5 million (2009), against an average of $73.5 million.
- Peak annual rise in Amortization - Intangibles reached 0.0% in 2010, while the deepest fall reached 0.0% in 2010.
- Amgen's Amortization - Intangibles stood at $73.0 million in 2009, then changed by 0.0% to $73.0 million in 2010, then changed by 0.0% to $73.0 million in 2011, then changed by 0.0% to $73.0 million in 2012.
- Business Quant data shows AMGN's Amortization - Intangibles at $73.0 million in Q4 2012, $74.0 million in Q3 2012, and $73.0 million in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 73.00 Mn |
| Sep 30, 2012 | 74.00 Mn |
| Jun 30, 2012 | 73.00 Mn |
| Mar 31, 2012 | 74.00 Mn |
| Dec 31, 2011 | 73.00 Mn |
| Sep 30, 2011 | 74.00 Mn |
| Jun 30, 2011 | 73.00 Mn |
| Mar 31, 2011 | 74.00 Mn |
| Dec 31, 2010 | 73.00 Mn |
| Sep 30, 2010 | 74.00 Mn |
| Jun 30, 2010 | 73.00 Mn |
| Mar 31, 2010 | 74.00 Mn |
| Dec 31, 2009 | 73.00 Mn |
| Sep 30, 2009 | 74.00 Mn |
| Jun 30, 2009 | 73.00 Mn |
| Mar 31, 2009 | 74.00 Mn |